Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Orogen Royalties Appoints Mr. Chad Wells to the Board of Directors
08:00am, Wednesday, 06'th May 2026
VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce the appointment of Mr. Chad Wells to the Company's Boar
BALA CYNWYD, Pa. , May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—OGN, MMTX, VRE, and ESQ
11:51am, Tuesday, 05'th May 2026
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders a
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 04'th May 2026
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:01am, Thursday, 30'th Apr 2026
The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Organon (OGN) Q1 Earnings and Revenues Miss Estimates
10:30am, Thursday, 30'th Apr 2026
Organon (OGN) came out with quarterly earnings of $0.71 per share, missing the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.02 per share a year ago.
Organon Reports Results for the First Quarter Ended March 31, 2026
07:30am, Thursday, 30'th Apr 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2026. First Quarter 2026 Revenue in $ millions Q1 2026 Q1 2025 VPY
Organon Cancels First Quarter Earnings Call
07:30am, Wednesday, 29'th Apr 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
Orogen Royalties Reports Record Revenue and Strong Earnings Growth in 2025
07:30am, Tuesday, 28'th Apr 2026
VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / (TSX:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to report record revenue and after-tax profit for the year ended
Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders
09:23pm, Monday, 27'th Apr 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholder
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
05:34pm, Monday, 27'th Apr 2026
Expand NYSE: OGN Organon & Co. Today's Change (16.87%) $1.90 Current Price $13.16 Key Data Points Market Cap $2.9B Day's Range $13.15 - $13.24 52wk Range $5.69 - $13.24 Volume 134M Avg Vol 5.8M Gross
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
01:15pm, Monday, 27'th Apr 2026
OGN stock soars as Sun Pharma strikes $11.75B all-cash deal, aiming to expand biosimilars reach and boost global pharma standing.
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?
11:24am, Monday, 27'th Apr 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Organon & Co. (NYSE: OGN) breached their
